Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
6.50
-0.28 (-4.13%)
At close: Dec 5, 2025, 4:00 PM EST
6.48
-0.02 (-0.36%)
After-hours: Dec 5, 2025, 5:58 PM EST
Vir Biotechnology Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 25.73, with a low estimate of 12 and a high estimate of 110. The average target predicts an increase of 295.85% from the current stock price of 6.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 15, 2025.
Analyst Ratings
The average analyst rating for Vir Biotechnology stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +130.77% | Sep 15, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $12 | Buy | Initiates | $12 | +84.62% | Sep 3, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $12 → $14 | Hold → Strong Buy | Upgrades | $12 → $14 | +115.38% | Aug 27, 2025 |
| Raymond James | Raymond James | Buy Initiates $12 | Buy | Initiates | $12 | +84.62% | Jul 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +115.38% | May 22, 2025 |
Financial Forecast
Revenue This Year
6.34M
from 74.21M
Decreased by -91.46%
Revenue Next Year
9.39M
from 6.34M
Increased by 48.05%
EPS This Year
-3.52
from -3.83
EPS Next Year
-2.96
from -3.52
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.5M | 19.0M | ||||
| Avg | 6.3M | 9.4M | ||||
| Low | 4.6M | 980,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -85.9% | 199.8% | ||||
| Avg | -91.5% | 48.1% | ||||
| Low | -93.8% | -84.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.17 | -2.42 | ||||
| Avg | -3.52 | -2.96 | ||||
| Low | -3.58 | -3.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.